AR033427A1 - Uso de compuestos carbamatos en el tratamiento del dolor - Google Patents

Uso de compuestos carbamatos en el tratamiento del dolor

Info

Publication number
AR033427A1
AR033427A1 ARP020100699A ARP020100699A AR033427A1 AR 033427 A1 AR033427 A1 AR 033427A1 AR P020100699 A ARP020100699 A AR P020100699A AR P020100699 A ARP020100699 A AR P020100699A AR 033427 A1 AR033427 A1 AR 033427A1
Authority
AR
Argentina
Prior art keywords
group
alkyl
phenyl
pain treatment
carbamate compounds
Prior art date
Application number
ARP020100699A
Other languages
English (en)
Spanish (es)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR033427A1 publication Critical patent/AR033427A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP020100699A 2001-02-27 2002-02-27 Uso de compuestos carbamatos en el tratamiento del dolor AR033427A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27188801P 2001-02-27 2001-02-27
US10/081,943 US6815464B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain

Publications (1)

Publication Number Publication Date
AR033427A1 true AR033427A1 (es) 2003-12-17

Family

ID=23037511

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100699A AR033427A1 (es) 2001-02-27 2002-02-27 Uso de compuestos carbamatos en el tratamiento del dolor

Country Status (28)

Country Link
US (1) US6815464B2 (cg-RX-API-DMAC10.html)
EP (1) EP1404312B1 (cg-RX-API-DMAC10.html)
JP (1) JP4276838B2 (cg-RX-API-DMAC10.html)
KR (1) KR100906315B1 (cg-RX-API-DMAC10.html)
CN (1) CN1849116A (cg-RX-API-DMAC10.html)
AR (1) AR033427A1 (cg-RX-API-DMAC10.html)
AT (1) ATE493125T1 (cg-RX-API-DMAC10.html)
AU (1) AU2002254015B2 (cg-RX-API-DMAC10.html)
BR (1) BR0207673A (cg-RX-API-DMAC10.html)
CA (1) CA2439274C (cg-RX-API-DMAC10.html)
CY (1) CY1111349T1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20032298A3 (cg-RX-API-DMAC10.html)
DE (1) DE60238765D1 (cg-RX-API-DMAC10.html)
DK (1) DK1404312T3 (cg-RX-API-DMAC10.html)
ES (1) ES2356617T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0303236A3 (cg-RX-API-DMAC10.html)
IL (1) IL157593A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA03007721A (cg-RX-API-DMAC10.html)
MY (1) MY129312A (cg-RX-API-DMAC10.html)
NO (1) NO20033804L (cg-RX-API-DMAC10.html)
NZ (1) NZ527994A (cg-RX-API-DMAC10.html)
PL (1) PL364647A1 (cg-RX-API-DMAC10.html)
PT (1) PT1404312E (cg-RX-API-DMAC10.html)
RS (1) RS67603A (cg-RX-API-DMAC10.html)
RU (1) RU2283106C2 (cg-RX-API-DMAC10.html)
TW (1) TWI304735B (cg-RX-API-DMAC10.html)
WO (1) WO2002067922A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200307475B (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007934A1 (en) * 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1998781A2 (en) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware Treatment of pain
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
EP2496227B1 (en) 2009-11-06 2019-05-22 SK Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
ES2447295T3 (es) 2009-11-06 2014-03-11 Sk Biopharmaceuticals Co., Ltd. Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN102266317A (zh) * 2011-06-24 2011-12-07 中国人民解放军第三军医大学 丙戊酸及其衍生物的应用
RU2632659C2 (ru) * 2011-12-27 2017-10-09 Байо-Фарм Солюшнс Ко., Лтд. Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
KR102421013B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2020972C1 (ru) * 1991-02-07 1994-10-15 Мегдятов Рашид Салехович Способ лечения невралгии тройничного нерва
US5698588A (en) 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
ATE226071T1 (de) * 1996-10-08 2002-11-15 Ortho Mcneil Pharm Inc Antikonvulsive derivate zur behandlung von neuropathischem schmerz
GB2340074A (en) * 1998-08-01 2000-02-16 Max Imaging Systems Limited Printing process
PL365701A1 (en) 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Also Published As

Publication number Publication date
KR100906315B1 (ko) 2009-07-07
JP2004523553A (ja) 2004-08-05
CZ20032298A3 (cs) 2004-08-18
AU2002254015B2 (en) 2006-08-24
ATE493125T1 (de) 2011-01-15
NO20033804L (no) 2003-09-30
RU2003128984A (ru) 2005-03-20
CA2439274C (en) 2011-04-05
WO2002067922A1 (en) 2002-09-06
PL364647A1 (en) 2004-12-13
TWI304735B (en) 2009-01-01
MXPA03007721A (es) 2004-11-12
KR20030076711A (ko) 2003-09-26
RU2283106C2 (ru) 2006-09-10
CA2439274A1 (en) 2002-09-06
JP4276838B2 (ja) 2009-06-10
NO20033804D0 (no) 2003-08-26
CY1111349T1 (el) 2015-08-05
EP1404312A1 (en) 2004-04-07
NZ527994A (en) 2005-11-25
US20020156127A1 (en) 2002-10-24
US6815464B2 (en) 2004-11-09
RS67603A (sr) 2007-02-05
MY129312A (en) 2007-03-30
EP1404312B1 (en) 2010-12-29
IL157593A0 (en) 2004-03-28
DK1404312T3 (da) 2011-03-14
DE60238765D1 (de) 2011-02-10
ZA200307475B (en) 2005-01-03
HUP0303236A3 (en) 2012-07-30
BR0207673A (pt) 2004-12-28
CN1849116A (zh) 2006-10-18
ES2356617T3 (es) 2011-04-11
PT1404312E (pt) 2011-02-01
HUP0303236A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
AR033426A1 (es) Uso de compuestos carbamatos en la prevencion o el tratamiento de trastornos de movimiento
ECSP088179A (es) Compuestos de carbamato para usarse en el tratamiento de desordenes neurodegenerativos
AR035756A1 (es) Uso de carbamatos en la preparacion de medicamentos para la prevencion o tratamiento de trastornos neurodegenerativos
AR054524A1 (es) Metodos y formas de dosificacion para reducir los efectos secundarios de compuestos de carbamato
YU68003A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
RU2003128984A (ru) Производные карбаматов для использования для лечения боли
IL157590A0 (en) Carbamate compounds for use in preventing or treating bipolar disorder
AR064241A1 (es) Metodos para el tratamiento de la depresion
AR032876A1 (es) Compuestos de carbamato para utilizar en la prevencion o tratamiento de los trastornos psicoticos
AR052885A1 (es) Metodos para el control del intervalo qt
DK1399144T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
DK1305082T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte
AR032907A1 (es) Uso de compuestos carbamatos para la prevencion o tratamiento de trastornos de ansiedad
IL159847A0 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AR034785A1 (es) Compuestos de carbamato para utilizarse en la prevencion o tratamiento de dolor neuropatico y dolor asociado con cefalea migranosa y cefalea acuminada
AR033545A1 (es) Uso de compuestos de carbamato para la fabricacion de medicamentos
AR034786A1 (es) Compuestos de carbamato para utilizarse en la prevencion o tratamiento de dolor neuropatico y dolor asociado con cefalea migranosa y cefalea acuminada
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
PE20060559A1 (es) Compuestos derivados de carbamato para el tratamiento de trastornos relacionados con sustancias

Legal Events

Date Code Title Description
FB Suspension of granting procedure